Advertisement

Novel In Vivo Investigation of the Brain Nociceptin/Orphanin FQ System in Alcohol Use Disorder: Are There Lessons From a Negative Neuroimaging Study?

  • Laura M. Best
    Affiliations
    Addiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, Ontario, Canada

    Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
    Search for articles by this author
  • Isabelle Boileau
    Correspondence
    Address correspondence to Isabelle Boileau, Ph.D., Centre for Addiction and Mental Health, Addiction Imaging Research Group, Head, 250 College St (PET Centre), Toronto, Ontario, M5T 1R8, Canada.
    Affiliations
    Campbell Family Mental Health Research Institute and Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada

    Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

    Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
    Search for articles by this author
      SEE CORRESPONDING ARTICLE ON PAGE 708
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Reinscheid R.K.
        • Nothacker H.P.
        • Bourson A.
        • Ardati A.
        • Henningsen R.A.
        • Bunzow J.R.
        • et al.
        Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor.
        Science. 1995; 270: 792-794
        • Meunier J.C.
        • Mollereau C.
        • Toll L.
        • Suaudeau C.
        • Moisand C.
        • Alvinerie P.
        • et al.
        Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor.
        Nature. 1995; 377: 532-535
        • Berthele A.
        • Platzer S.
        • Dworzak D.
        • Schadrack J.
        • Mahal B.
        • Büttner A.
        • et al.
        [3H]-nociceptin ligand-binding and nociceptin opioid receptor mRNA expression in the human brain.
        Neuroscience. 2003; 121: 629-640
        • Tollefson S.
        • Himes M.
        • Narendran R.
        Imaging corticotropin-releasing-factor and nociceptin in addiction and PTSD models.
        Int Rev Psychiatry. 2017; 29: 567-579
        • Witkin J.M.
        • Statnick M.
        • Rorick-Kehn L.
        • Pintar J.E.
        • Ansonoff M.
        • Chen Y.
        • et al.
        The biology of nociceptin/orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood and drug dependence.
        Pharmacol Ther. 2014; 141: 283-299
        • Post A.
        • Smart T.S.
        • Jackson K.
        • Mann J.
        • Mohs R.
        • Rorick-Kehn L.
        • et al.
        Proof-of-concept study to assess the nociceptin receptor antagonist LY2940094 as a new treatment for alcohol dependence.
        Alcohol Clin Exp Res. 2016; 40: 1935-1944
        • Lohith T.G.
        • Zoghbi S.S.
        • Morse C.L.
        • Araneta M.F.
        • Barth V.N.
        • Goebl N.A.
        • et al.
        Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11CNOP-1A.
        J Nucl Med. 2012; 53: 385-392
        • Narendran R.
        • Ciccocioppo R.
        • Lopresti B.
        • Paris J.
        • Himes M.L.
        • Mason N.S.
        Nociceptin receptors in alcohol use disorders: A positron emission tomography study using [11C]NOP-1A.
        Biol Psychiatry. 2018; 84: 708-714
        • Kuzmin A.
        • Bazov I.
        • Sheedy D.
        • Garrick T.
        • Harper C.
        • Bakalkin G.
        Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics.
        Brain Res. 2009; 1305: S80-S85
        • Lutz P.
        • Zhou Y.
        • Labbe A.
        • Mechawar N.
        • Turecki G.
        Decreased expression of nociceptin/orphanin FQ in the dorsal anterior cingulate cortex of suicides.
        Eur Neuropsychopharmacol. 2015; 25: 2008-2014

      Linked Article

      • Nociceptin Receptors in Alcohol Use Disorders: A Positron Emission Tomography Study Using [11C]NOP-1A
        Biological PsychiatryVol. 84Issue 10
        • Preview
          The neuropeptide transmitter nociceptin, which binds to the nociceptin/orphanin FQ peptide (NOP) receptor, is a core component of the brain's antistress system. Nociceptin exerts its antistress effect by counteracting the functions of corticotropin-releasing factor, the primary stress-mediating neuropeptide in the brain. Basic investigations support a role for medications that target nociceptin receptors in the treatment of alcohol use disorders. Thus, it is of high interest to measure the in vivo status of NOP receptors in individuals with alcohol use disorders.
        • Full-Text
        • PDF